Clinical implications of circulating angiogenic factors in cancer patients.

By R. Poon, S. Fan, J. Wong. Journal of Clinical Oncology, 2001

611 citations recorded by the source corpus.

Subfields: Immunology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/7121197bd3bb93fa70a2f773d5ceab1bdbda24b7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. A. V. van Oosterom
2. A. Hoeben
3. E. D. de Bruijn
4. M. Highley
5. H. Wildiers
6. B. Landuyt

Citations in the corpus

• Vascular Endothelial Growth Factor and Angiogenesis (2004, background): “Data in the literature suggest that the circulating VEGF-A level is a useful marker of tumor status and prognosis in most types of human cancer (Toi et al., 1995; Chin et al., 2000; Linderholm et al., 2000, 2001; Poon et al., 2001).”
• Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. (2005, background): “The clinical significance of circulating FGF2 in individual types of cancer has been recently reviewed [201].”